The most important financial indicators for the company Worwag Pharma Romania Srl - Unique Identification Number 38251840:
sales in 2023 was
31.170.871
euro, registering a net profit of
610.029
euro and having an average number of
80
employees.
Firma isi desfasoara activitatea in domeniul Comert cu ridicata al produselor farmaceutice having the NACE code 4646.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales decreased by -14.4%, from 36.508.438 euro in the year 2022, to 31.170.871 euro in 2023.
The Net Profit increased by 116.916 euro, from 494.614 euro in 2022, to 610.029 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Worwag Pharma Romania Srl - CUI 38251840
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
-
-
-
14.040
15.001
43.717
731.269
724.943
900.431
1.183.099
Current Assets
-
-
-
143.281
487.546
880.974
25.368.811
27.850.518
22.431.716
18.363.232
Inventories
-
-
-
0
0
0
6.257.768
3.064.460
2.203.817
784.196
Receivables
-
-
-
16.540
450.142
849.042
18.971.760
19.910.212
19.118.987
14.871.359
Cash
-
-
-
126.741
37.404
31.932
139.284
4.875.846
1.108.912
2.707.677
Shareholders Funds
-
-
-
-70.613
-10.278
83.213
1.036.227
2.304.150
2.805.913
3.407.433
Social Capital
-
-
-
10.945
10.745
10.537
10.337
10.108
10.139
10.108
Debts
-
-
-
232.494
539.227
890.961
25.085.201
26.293.768
20.535.752
16.147.328
Income in Advance
-
-
-
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"4646 - 4646"
CAEN Financial Year
4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
18.363.232 euro in 2023 which includes Inventories of
784.196 euro, Receivables of
14.871.359 euro and cash availability of
2.707.677 euro.
The company's Equity was valued at
3.407.433 euro, while total Liabilities amounted to
16.147.328 euro.
Equity increased by 610.029 euro, from 2.805.913 euro in 2022, to 3.407.433 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Worwag Pharma Romania Srl